SCOPUS 정보 검색 플랫폼

Clinical Cancer Research

Volumn 6, Issue 11, 2000, Pages 4201-4204

Phase I trial of paclitaxel plus megestrol acetate in patients with paclitaxel-refractory ovarian cancer

(6) Markman, M a Kennedy, A a Webster, K a Kulp, B a Peterson, G a Belinson, J a

a LERNER RESEARCH INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; DOXORUBICIN; GLYCOPROTEIN P; MEGESTROL ACETATE; PACLITAXEL; PROGESTERONE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; GYNECOLOGIC CANCER; HUMAN; MULTIDRUG RESISTANCE; OVARY CANCER; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; MEGESTROL ACETATE; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL;

EID: 0033730357 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (11)

References (17)

1
- 0030054309
- Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
- (1996) N. Engl. J. Med. , vol.334 , pp. 1-6
- McGuire, W.P.¹ Hoskins, W.J.² Brady, M.F.³ Kucera, P.R.⁴ Partridge, E.E.⁵ Look, K.Y.⁶ Clarke-Pearson, D.L.⁷ Davidson, M.⁸

2
- 0028308901
- Multidrug resistance in cancer chemotherapy
- (1994) Investig. New Drugs , vol.12 , pp. 1-13
- Patel, N.H.¹ Rothenberg, M.L.²

3
- 0027472165
- Mechanisms of drug resistance in ovarian cancer
- (1993) Cancer (Phila.) , vol.71 , pp. 644-649
- Johnson, S.W.¹ Ozols, R.F.² Hamilton, T.C.³

4
- 0027500721
- Reversal of multidrug resistance to cancer chemotherapy
- (1993) Cancer (Phila.) , vol.72 , pp. 3484-3488
- Leyland-Jones, B.¹ Dalton, W.² Fisher, G.A.³ Sikic, B.I.⁴

5
- 0027136660
- Clinical trials of agents that reverse multidrug resistance
- (1993) Cancer (Phila.) , vol.72 , pp. 3553-3563
- Raderer, M.¹ Scheithauer, W.²

6
- 0026341150
- Phase I pharmacokinetic study of D-verapamil and doxorubicin
- (1991) Br. J. Cancer , vol.64 , pp. 1168-1171
- Bissett, D.¹ Kerr, D.J.² Cassidy, J.³ Meredith, P.⁴ Traugott, U.⁵ Kaye, S.B.⁶

7
- 0030580037
- Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate
- (1996) Biochem. Pharmacol. , vol.52 , pp. 1097-1102
- Panasci, L.¹ Jean-Claude, B.J.² Vasilescu, D.³ Mustafa, A.⁴ Damian, S.⁵ Damian, Z.⁶ Georges, E.⁷ Liu, Z.⁸ Batist, G.⁹ Leyland-Jones, B.¹⁰

8
- 0031027324
- Augmentation of vincristine cytotoxicity by megestrol acetate
- (1997) Cancer Chemother. Pharmacol. , vol.39 , pp. 333-340
- Tansan, S.¹ Koc, Y.² Aydin, H.³ Urbano, G.⁴ McCaffrey, R.⁵

9
- 0027518135
- Clinical trials of modulation of multidrug resistance
- (1993) Cancer (Phila.) , vol.72 , pp. 3502-3514
- Lum, B.L.¹ Fisher, G.A.² Brophy, N.A.³ Yahanda, A.M.⁴ Adler, K.M.⁵ Kaubisch, S.⁶ Halsey, J.⁷ Sikic, B.I.⁸

10
- 0024501045
- Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus
- (1989) J. Biol. Chem. , vol.264 , pp. 782-788
- Yang, C.-P.H.¹ DePinho, S.G.² Greenberger, L.M.³ Arceci, R.J.⁴ Horwitz, S.B.⁵

11
- 0028283470
- Reversal of the human and murine multidrug-resistance pheno-type with megestrol acetate
- (1994) Cancer Chemother. Pharmacol. , vol.34 , pp. 96-102
- Wang, L.¹ Yang, C.-P.H.² Horwitz, S.B.³ Trail, P.A.⁴ Casazza, A.M.⁵

12
- 0026572562
- Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein
- (1992) Cancer Chemother. Pharmacol. , vol.29 , pp. 445-449
- Fleming, G.F.¹ Amato, J.M.² Agresti, M.³ Safa, A.R.⁴

13
- 0027332882
- Phase I/pharmacokinetic study of high-dose progesterone and doxorubicin
- (1993) J. Clin. Oncol. , vol.11 , pp. 2417-2426
- Christen, R.D.¹ McClay, E.F.² Plaxe, S.C.³ Yen, S.S.C.⁴ Kim, S.⁵ Kirmani, S.⁶ Wilgus, L.L.⁷ Heath, D.D.⁸ Shalinsky, D.R.⁹ Freddo, J.L.¹⁰ Braly, P.S.¹¹ O'Quigley, J.¹² Howell, S.B.¹³

14
- 0032144047
- Phase 2 trial of single agent ifosfamide/MESNA in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent
- (1998) Gynecol. Oncol. , vol.70 , pp. 272-274
- Markman, M.¹ Kennedy, A.² Sutton, G.³ Hurteau, J.⁴ Webster, K.⁵ Peterson, G.⁶ Kulp, B.⁷ Belinson, J.⁸

15
- 0023838264
- Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer
- (1988) J. Cancer Res. Clin. Oncol. , vol.114 , pp. 186-190
- Miller, A.A.¹ Becher, R.² Schmidt, C.G.³

16
- 0022868281
- High-dose megestrol acetate therapy of ovarian carcinoma: A Phase II study by the Northern California Oncology Group
- (1986) Semin. Oncol. , vol.13 , pp. 26-32
- Sikic, B.I.¹ Scudder, S.A.² Ballon, S.C.³ Soriero, O.M.⁴ Christman, J.E.⁵ Suey, L.⁶ Ehsan, M.N.⁷ Brandt, A.E.⁸ Evans, T.L.⁹

17
- 0026989383
- Why haven't we cured multidrug resistant tumors?
- (1992) Oncol. Res. , vol.4 , pp. 1-6
- Murren, J.R.¹ Hait, W.N.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.